首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   35381篇
  免费   3406篇
  国内免费   397篇
耳鼻咽喉   328篇
儿科学   2052篇
妇产科学   389篇
基础医学   3910篇
口腔科学   532篇
临床医学   3113篇
内科学   2503篇
皮肤病学   220篇
神经病学   14927篇
特种医学   323篇
外科学   1100篇
综合类   2702篇
现状与发展   2篇
一般理论   1篇
预防医学   3026篇
眼科学   127篇
药学   2870篇
  7篇
中国医学   841篇
肿瘤学   211篇
  2024年   102篇
  2023年   854篇
  2022年   1048篇
  2021年   1831篇
  2020年   1738篇
  2019年   1649篇
  2018年   1528篇
  2017年   1610篇
  2016年   1659篇
  2015年   1442篇
  2014年   2385篇
  2013年   3319篇
  2012年   1857篇
  2011年   2275篇
  2010年   1756篇
  2009年   1766篇
  2008年   1795篇
  2007年   1648篇
  2006年   1353篇
  2005年   1136篇
  2004年   924篇
  2003年   838篇
  2002年   730篇
  2001年   521篇
  2000年   421篇
  1999年   365篇
  1998年   405篇
  1997年   325篇
  1996年   249篇
  1995年   206篇
  1994年   174篇
  1993年   160篇
  1992年   160篇
  1991年   152篇
  1990年   126篇
  1989年   121篇
  1988年   107篇
  1987年   82篇
  1986年   44篇
  1985年   78篇
  1984年   50篇
  1983年   32篇
  1982年   53篇
  1981年   30篇
  1980年   19篇
  1979年   18篇
  1978年   13篇
  1977年   12篇
  1976年   7篇
  1974年   5篇
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
31.
Introduction: Major Depressive Disorder (MDD) and General Anxiety Disorder (GAD) significantly contribute to the global burden of disease. Vilazodone, a combined serotonin reuptake inhibitor and 5-HT1A partial agonist, is an approved therapy for the treatment of MDD and which has been further investigated for GAD.

Areas covered: This article covers the pharmacokinetics and pharmacodynamics of vilazodone and provides an evaluation of the clinical usefulness of vilazodone for the treatment of MDD and anxiety disorders. A literature search was performed using PubMed/MEDLINE, Web of Science and the Cochrane Library.

Expert opinion: Studies have shown that vilazodone is significantly superior to placebo. However, vilazodone cannot as yet be recommended as a first-line treatment option for MDD as it is unclear whether the drug’s dual mechanism of action provides greater efficacy than prevailing treatment options. Moreover, more phase IV studies are needed to establish its efficacy and long-term safety in larger and more diverse populations. Although vilazodone may have an additional advantage for the treatment of anxiety symptoms in MDD, here also additional studies are required to confirm its efficacy over and above SSRI alternatives and other antidepressant treatments. Therefore, presently, vilazodone should be considered as a second- or third-line treatment option for MDD and GAD.  相似文献   

32.
33.
34.
不寐,现代医学称睡眠障碍,是一种临床常见病和多发病,本病发病原因尚不明确,通常不伴明显器质性病变,病人自觉症状重,西医尚无明确的治愈方法。祖国医学很早就认识到本病,积累了丰富的经验。刘中勇教授在古人的基础上提出从"气血瘀滞"的角度论治不寐,临床取得较好疗效,本文将从病因病机、理论探析、辨证论治三个方面介绍其相关经验,供同行参考。  相似文献   
35.
Pelvic venous disorders (PeVDs) in women can present with chronic pelvic pain, lower-extremity and vulvar varicosities, lower-extremity swelling and pain, and left-flank pain and hematuria. Multiple evidence gaps exist related to PeVDs with the consequence that nonvascular specialists rarely consider the diagnosis. Recognizing this, the Society of Interventional Radiology Foundation funded a Research Consensus Panel to prioritize a research agenda to address these gaps. This paper presents the proceedings and recommendations from that Panel.  相似文献   
36.
37.
38.
Background: The opioid addiction and overdose crisis continues to ravage communities across the U.S. Maintenance pharmacotherapy using buprenorphine or methadone is the most effective intervention for Opioid Use Disorder (OUD), yet few have immediate and sustained access to these medications. Objectives: To address lack of medication access for people with OUD, the Missouri Department of Mental Health began implementing a Medication First (Med First) treatment approach in its publicly-funded system of comprehensive substance use disorder treatment programs. Methods: This Perspective describes the four principles of Med First, which are based on evidence-based guidelines. It draws conceptual comparisons between the Housing First approach to chronic homelessness and the Med First approach to pharmacotherapy for OUD, and compares state certification standards for substance use disorder (SUD) treatment (the traditional approach) to Med First guidelines for OUD treatment. Finally, the Perspective details how Med First principles have been practically implemented. Results: Med First principles emphasize timely access to maintenance pharmacotherapy without requiring psychosocial services or discontinuation for any reason other than harm to the client. Early results regarding medication utilization and treatment retention are promising. Feedback from providers has been largely favorable, though clinical- and system-level obstacles to effective OUD treatment remain. Conclusion: Like the Housing First model, Medication First is designed to decrease human suffering and activate the strengths and capacities of people in need. It draws on decades of research and facilitates partnerships between psychosocial and medical treatment providers to offer effective and life-saving care to persons with OUD.  相似文献   
39.
Cerebral Palsy motor disorder triggers orthopedic complications. These complications do develop by themselves and gradually degrade the motor function. The functioning of the ventilatory pump is no exception to this process. Other orthopedic impairments are impacting more indirectly ventilation. Some orthopedic treatments used for PC people are likely to worsen this clinical situation, temporarily or more permanently. Any therapeutic intervention must include two essential points: acting previously to realign posture and considering interactions of treatments on different functions.  相似文献   
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号